IL22280A - Asymmetrical pyridoxolyl disulphides and their preparation - Google Patents
Asymmetrical pyridoxolyl disulphides and their preparationInfo
- Publication number
- IL22280A IL22280A IL22280A IL2228064A IL22280A IL 22280 A IL22280 A IL 22280A IL 22280 A IL22280 A IL 22280A IL 2228064 A IL2228064 A IL 2228064A IL 22280 A IL22280 A IL 22280A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- reaction
- preparation
- melting point
- compound according
- Prior art date
Links
- 238000006243 chemical reaction Methods 0.000 description 24
- 238000002844 melting Methods 0.000 description 24
- 230000008018 melting Effects 0.000 description 24
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 22
- 150000001875 compounds Chemical class 0.000 description 20
- 239000000243 solution Substances 0.000 description 16
- 239000002253 acid Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 13
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- -1 alkyl radical Chemical class 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 125000002252 acyl group Chemical group 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 239000000155 melt Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 150000003222 pyridines Chemical class 0.000 description 4
- 238000007127 saponification reaction Methods 0.000 description 4
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 4
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical class SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- MIZBWIBHGBTKCY-UHFFFAOYSA-N (cyanodisulfanyl) thiocyanate Chemical class N#CSSSC#N MIZBWIBHGBTKCY-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- QGJOPFRUJISHPQ-UHFFFAOYSA-N carbon disulphide Natural products S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- QWTDNUCVQCZILF-UHFFFAOYSA-N isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical group O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000006193 alkinyl group Chemical group 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- IEJSIQMFHIVOAR-UHFFFAOYSA-N butoxy-hydroxy-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound CCCCOS(O)(=O)=S IEJSIQMFHIVOAR-UHFFFAOYSA-N 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- ZASWJUOMEGBQCQ-UHFFFAOYSA-L dibromolead Chemical compound Br[Pb]Br ZASWJUOMEGBQCQ-UHFFFAOYSA-L 0.000 description 1
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- BOOUBOHCWRMCOG-UHFFFAOYSA-N dodecoxy-hydroxy-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound CCCCCCCCCCCCOS(O)(=O)=S BOOUBOHCWRMCOG-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- KONZICNQWURKQP-UHFFFAOYSA-N hydroxy-oxo-phenoxy-sulfanylidene-$l^{6}-sulfane Chemical compound OS(=O)(=S)OC1=CC=CC=C1 KONZICNQWURKQP-UHFFFAOYSA-N 0.000 description 1
- XWEBSKRLUGLUTN-UHFFFAOYSA-N hydroxy-oxo-phenylmethoxy-sulfanylidene-$l^{6}-sulfane Chemical compound OS(=O)(=S)OCC1=CC=CC=C1 XWEBSKRLUGLUTN-UHFFFAOYSA-N 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 125000004999 nitroaryl group Chemical group 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940068917 polyethylene glycols Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Substances [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 150000004764 thiosulfuric acid derivatives Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
PATENTS FORM Γ anraeys PATENTS COMPLETE SPECIFICATION Asymmetrical disulphides and their MERCK a German Body of Frankfurterstrasse do hereby declare the for which we pray that a patent may be granted to and the method by which it is to be to be particularly described in and by the following statement 22280 File 12615 The invention relates to asymmetrical pyridoxolyl disulphides and to methods for thei We have that pyridoxolyl derivatives of the where and H or carboxylic acyl groups and is an optionally acyl or l radical aryloxy an optionally halogen or nitro aryl or radical or an alkenyl or and their salts are pharmacologically active They may be thought of as being vitamin its acyl The present invention provides compounds of the above and their salts new compounds pharmaceutical or their salts these compounds their The novel compounds of formula I can be prepared by reacting a pyridine derivative formula 22280 Pile 12615 where and are previously de ned and is an group or an equivalen of a metal preferably with a compound of formula Y is C or and and are as previously 22280 File 12615 which the acyl groups may be is a branched substituted or unsubstituted alkyl radical which generally not have more tha 20 carbon Suitable alkyl radicals are the lower alkyl radicals preferably with up to 6 carbon atoms such amyl and but also the alkyl groups such as octy When is an alkyl group it ma be unsubstituted or mono or poly substituted in various by acyloxy groups or aliphatic aromatic monocarboxylic acids containing up to carbon more particularly utoxy and amyloxy or carbpbenzoxy or cinnamoylox The alkyl radical may also be substituted by an esterified carboxyl group containing up to carbon for may also denote an alkenyl This may contain one or more double but generally does not contain more than Preferred alkenyl radicals are all 22280 12615 Preferred alkinyl groups are ethinyl and If denotes an aryl then phenyl or naphthyl are Aralkyl are in the benzyl and phenethyl If the aromatic particularly the phenyl is tuents are preferably halogens such as or lower up to carbon more particularly and amyl groups or nitro The following substituted aryl radicals are given by wa of or o The two methods fo the preparation of the novel compounds will now be described in more Reaction A compound of formula II is advantageously reacted with acid derivatives preferably Bunte salts salts of alkylthiosulphuric in alkaline solution in water for example in lower aliphatic dioxan or 22280 alkaline additives for or The reactions are carried out a temperature of from and under normal The reaction between a pyridine compound of formula II and those formula III compounds in which Y denotes is advantageously out i substantially highly acid or highiy alkaline solutions yields of the required products generally fall off Polar solvents more particularly alcohols such as propanol and isopropanol are particularly suitable the The reaction may be performed both in anhydrous and aqueous The reaction temperatures are generally between 0 and but preferably it is carred out at room It is generally sufficient merely to let the reaction mixture stand fo some The reaction of the pyridine derivatives of formula II with substituted sulphonyl or or substituted formula III also carried in a inert solvents advantageously being as the reaction etherj 22280 Pile 12615 carbondisulphide ethyl the reaction mixture left for some hours at room the reaction may carried out at elevated The sulphenyl thiocyanates Y required for the reaction are prepared b reaction of metallic salts anic acid with the corresponding substituted mecaptan derivatives and need not in the form of pure products in the reaction but can used without isolation directly in the solution obtained during their Reaction B Inert as chlorinated carbon disulphide or are again used for the reaction of a pyridine derivative of formula IV Z denotes the mercaptan derivatives of formula Here agai it is advisable to leave the reaction mixture for some for example room although the reaction be heated if on the a pyridine derivative of formula IV in which Z denotes is reacted with a mercaptan derivative of formula V it is advantageous to perform the reaction in water in for example in aliphatic or tetrahyd The pH of the reaction mixture is advantageously above preferably between 7 and aqueous solutions potassium or ammonium hydroxide are added obtain these pH As previously compounds of formula I an be converted to the corresponding acylated Any acylation process may employed for this Particularly advantageous is reaction with the corresponding acid anhydrides or acid chlorides of the requisite acid in the presence of alkaline more particularly the acid chlorides preferably being used for the introduction of the Those compounds I in which R denote an acyl radical may also be converted to the corresponding compounds by with saponification The saponification can be carried out by any for example by the action of dilute acids or Saponification by leaving the mixture at room temperature for a relatively long period with dilute for example hydrochloric is particularly Saponification can also be carried out by the action of aqueous or solutions for carbonate or sodium hydrogen carbonate the acyl The reaction products are in each case isolated by procedures known to those skilled in the for by precipitation an appropriate by evaporation of the by extraction or by chromatographic Conversion ormula I compounds to their salts is also carried out in a manner known in the for reaction with the appropriate acid in a inert In principle any acid which yields a physiologically compatible salt may be used this The following acids are particularly nitric and methane sulphonic acid and alkylsulphonic acids such as If the novel compounds are isolated in the form they can be converted into the free bases by any conventional methods such as neutralisation the solution of the acid addition salt followed by isolation the liberated The formula II starting materials are known from File 12615 Patent Spedification or can be prepared om treatment with an agent or with hydroxide or ammonium Formula compounds i which denotes obtained by reaction of the basic me compound with the corresponding The starting materials of formula III in which Y denotes may be obtained by reaction of the corresponding halides with solium The thiosulphate acid derivatives of formula can be prepared by oxidation of the with The hiosulphonic acid derivatives of formula III finally form when the correspondingly substituted thiosulphinic acids are heated in thiosulphonates precipitating by The sulphenylthiocyanates of formula III which are also used as starting material as already by reaction of rhodanides with correspondingly substituted mercaptan The following formulae illustrate certain examples of the novel i 22280 File 12615 where substituted pplysubstituted with pre erable not more than 6 carbon atoms in the The substitutes may be acyloxy groups acyls or aliphatic or aromatic monocarboxylic con taining up to 9 carbon atoms or a esterifled group containin up to 9 carbon atoms ethinyl or prdpargyl 22280 12615 lkyl where n 1 phenyl where substituted phenyl is polysubstituted substituted by or lower alkyl with up to 5 carbon atoms or nitro 22280 12615 where benzyl may be or substituted by halogens or lower with up to 5 carbon atoms or In each of the above formulae and meanings previously ascribed to If are the following compounds will be of particular and The new compounds and their salts may be used as drugs and be applied wherever vitamin therapy is They are used more particularly for the treatment of disorders of cerebral As compared with known symmetrical pyridixolyldlsulphides the new compounds have better They therefore penetrate the cell membranes more easil and thus absorbed more satisfactorily by the rich nerve They can be used in admixture with conventional drug excipients in human 6r veterinary The excipients will be those organic or inorganic substances which are suitable parenteral or enteral application which do not react with the new for example vegetable polyethyleneglycols magnesium petroleum jelly and parenteral application there will be in solutions preferably oil or and suspensions or emulsions if may be sterilised or mixed with such as stabilisers or wetting or salts for influencing osmotic pressure or buffer Tablets or pills are particularly suitable for enteral The new compounds can of course be combined with other drugs if they are compatible Combinations with vitamins are particularly In order the invention may be more fully understood the following Examples are given by way of illustration Example 1 g of are dissolved in a mixture of 15 ml of water and 25 ml of hydroxide solution and g of butyl thiosulphate are The reaction mixture is left for 10 minutes at temperature and precipitate filtered off After the resultant melts 2 g of are left overnight at with 10 ml of pyridine and 10 ml of acetic Water is then added to the reaction The oil which separates in these conditions is taken up in ethyl The solution is dried over sodium sulphate and the solvent is The residue melts at after recrystallisati Example 2 120 g of oxymeth are slowly added to 800 ml of acetyl chloride with intensive agitation and cooling with and the mixture is then boiled for 2 hours under The precipitated is filtered off by dissolved in and the aqueous solution adjusted to a of with dilute The precipitated is filtered off by suction and recrystallised from Melting point Yield g the compound obtained in this way are suspended in ml of alcohol a solution of g sodium thiosulphate in 10 ml of water is added with The mixture is heated at for then filtered and ml of ether are The precipitated is removed by suction and recrystallised from Melting point 9 S the thiosulphate obtained in this way are added to a solution of S of in 25 ml of reaction mixture is left at room temperature for five minutes and the separated oil is taken up in ethyl It is dried over sodium sulphate and The oily residue disulphide crystallises on rubbing with Melting point Yield g of are left for 2 hours at room temperature in IN hydrochloric The solution is neutralised 2N sodium bicarbonate After processing g of is Melting point Example 3 g mercapto dissolved 0 ml of NaOH and g of laurylthiosulphate is The reaction mixture is heated for minutes at The precipitated is filtered off by suction and from Melting Yield Example 4 g propyl ester are dissolved in of methanol and a solution of g of in 100 ml of methanol is being left at room temperature for 6 ml of ether is The precipitated is filtered off by suction and recrystallised from Melting point Yield 19 If the ether is adjusted to about by the addition of the free base can be Melting point 11 Example g of isopentane thiosulphonic ester are dissolved in 30 ml of absolute alcohol and a solution of g of of absolute alcohol After being left for 12 hours at room temperature the reaction mixture is inspissated in vacuo until 2N aqueous sodium hydrogen carbonate solution is added to the The precipitated is filtered by suction and recrystallised from Melting point Yield Example 6 g of lead rhodanide are suspended in 150 ml of absolute ether of bromine is added at When the solution has lost colour the precipitated lead bromide is filtered off by suction and a solution S in 100 ml of slowly added the filtrate at a temperature of A solution of Pile 12615 in 100 of then added to the reaction After the been left overnight of ethe The separated oil is dissolved in 50 ml of hydrochloric The undissolved fraction filtered off by The filtrate is inspissated until the residue taken up in and then extracted with ethyl acetate The precipitated are eliminated from the ethyl acetate solution and the latter is dried over After inspissation and recrystallisation from ethyl acetate the melts at 108 Yield 4 Example g of are dissolved in 100 ml of dimethylformamidei g of benzene sulphonyl chloride in 50 ml of ormamide is added to the The reaction mixture is agitated at room temperature for 2 hours and then left The precipitate is filtered off by suction and the filtrate inspissated to about of its original volume and 500 ml tered off by with 20 ml of chloric acid and recrystallised from The resultant melts at Yield i Example compounds prepared in the same way as in Example 1 by reaction of with the corresponding thiosulphates Melting point Melting point Melting point Melting point Melting point 1 Melting point Melting Melting point Melting point Example By the process described in Example S of pyridine are reacted with benzylthiosulphate to Melting point 1 10 By described in Example S pyridine are reacted phenylthiosulphate to form Melting point Example 11 By the process described in Example S of pyridine are reacted with to form Melting point Example 12 By the process described in Example S pyridine are reacted with sulphate to form Melting point Example 13 By the process described in Example g of pyridine are reacted with g of thiosulphate to form pyrid Melting point 1 Example By the process described in Example g of pyridine are reacted g of sulphate to Melting point Example 1 By the process described in Example 1 g of pyridine are reacted with 9 g of to point Example 16 By the process described in Example 1 g of 1 pyridine are reacted with g of to form Melting point Example 1 By the process described in Example 1 g of pyridine are reacted with 8 g of thiosulphate to point insufficientOCRQuality
Claims (1)
1. 22280 Pilel2615 NOW particularly described and ascertained the nature of our said invention and in what manner the same to be we declare tha what claim A compound of the earboxylic acyl or aryloxy substituted allcyl radical alkyl an alkinyl radical or an optionally halogen or nitro aryl or aralkyl A compound according to Claim in which the substituted alkyl group contains not more than 6 carbon atoms in its A salt a compound according to any of Claims 1 and 20 22280 Pile 12615 lp ide 22280 12615 A process for the of a compound of the where and have the meanings ascribed to them in which process comprises the step of reacting a compound of the where an ammonium an equivalent of a metal with compound of the where T is or process according to Claim in which metal is A process for production of a compound of the y 12615 process for the preparation of a compound according to Claim substantially as herein described in any of the Examples A process for the preparation of a compound according to substantially as herein a o E A pharmaceutical composition comprising a compound according to any of Claims 1 to association with an pharmaceutical A preparation according to Claim which also comprises a insufficientOCRQuality
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEM0058865 | 1963-11-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL22280A true IL22280A (en) | 1968-12-26 |
Family
ID=7309364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL22280A IL22280A (en) | 1963-11-09 | 1964-10-19 | Asymmetrical pyridoxolyl disulphides and their preparation |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US3324140A (en) |
| BE (1) | BE655454A (en) |
| BR (1) | BR6464084D0 (en) |
| CH (1) | CH463502A (en) |
| DE (1) | DE1470054A1 (en) |
| DK (1) | DK111750B (en) |
| ES (1) | ES305791A1 (en) |
| FR (1) | FR4036M (en) |
| GB (1) | GB1032377A (en) |
| IL (1) | IL22280A (en) |
| NL (1) | NL146159B (en) |
| SE (1) | SE315894B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5137877B1 (en) * | 1990-05-14 | 1996-01-30 | Bristol Myers Squibb Co | Bifunctional linking compounds conjugates and methods for their production |
| US7282590B2 (en) * | 2004-02-12 | 2007-10-16 | The Research Foundation Of State University Of New York | Drug conjugates |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1915334A (en) * | 1930-10-16 | 1933-06-27 | Du Pont | Fluosilicate of organic heterocyclic bases and process of making it |
| US2075359A (en) * | 1930-10-16 | 1937-03-30 | Du Pont | Insecticide |
| BE633927A (en) * | 1958-03-21 | |||
| US3039930A (en) * | 1960-04-06 | 1962-06-19 | Irwin Neisler And Co | Pyridyl carbamyl lower alkane derivatives: analgesic process |
-
1963
- 1963-11-09 DE DE19631470054 patent/DE1470054A1/en active Pending
-
1964
- 1964-09-01 CH CH1143064A patent/CH463502A/en unknown
- 1964-10-12 GB GB41490/64A patent/GB1032377A/en not_active Expired
- 1964-10-19 IL IL22280A patent/IL22280A/en unknown
- 1964-11-04 DK DK543364AA patent/DK111750B/en unknown
- 1964-11-05 NL NL646412891A patent/NL146159B/en unknown
- 1964-11-05 SE SE13329/64A patent/SE315894B/xx unknown
- 1964-11-07 ES ES0305791A patent/ES305791A1/en not_active Expired
- 1964-11-09 FR FR994343A patent/FR4036M/fr not_active Expired
- 1964-11-09 BE BE655454D patent/BE655454A/xx unknown
- 1964-11-09 BR BR164084/64A patent/BR6464084D0/en unknown
- 1964-11-09 US US409950A patent/US3324140A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GB1032377A (en) | 1966-06-08 |
| CH463502A (en) | 1968-10-15 |
| SE315894B (en) | 1969-10-13 |
| NL146159B (en) | 1975-06-16 |
| BE655454A (en) | 1965-05-10 |
| BR6464084D0 (en) | 1973-07-26 |
| FR4036M (en) | 1966-03-28 |
| DE1470054A1 (en) | 1969-05-29 |
| US3324140A (en) | 1967-06-06 |
| ES305791A1 (en) | 1965-04-16 |
| NL6412891A (en) | 1965-05-10 |
| DK111750B (en) | 1968-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3238224A (en) | Production of 6, 8-dithiooctanoyl amides | |
| IL22280A (en) | Asymmetrical pyridoxolyl disulphides and their preparation | |
| US3064003A (en) | Carboxylic acid derivatives of sub- | |
| JPS6246540B2 (en) | ||
| US3160631A (en) | Derivatives of cephalosporin c | |
| US2749347A (en) | 2-phenylquinoline-3-aryl carbamates | |
| JPS6133131A (en) | Manufacture of thio, dithio or carbonyl group-containing organic compound | |
| IL28401A (en) | Arylsulfonyl ureas,their manufacture and pharmaceutical compositions containing them | |
| US2958692A (en) | S-carboxymethylmercapto-g- | |
| US3810922A (en) | Sulfur-containing 4-hydroxycoumarins and their salts | |
| US3661931A (en) | Process for preparing 1-methyl-2,3,5,6-tetrahydro - 5 - semicarbazido-6-hydroxy-indole - 3 - sulphonic acid and alkali metal salts thereof | |
| US2413833A (en) | Substituted 4,4'-diaminodiphenyl sulfones and process of making same | |
| US3117131A (en) | Method for producing indoline-6-sulfonamides | |
| US3076800A (en) | Jj-lactams unsubstituted at the nitrogen | |
| US2691651A (en) | Preparation of alkali metal and alkaline earth metal penicillinates | |
| US2776290A (en) | Hydroxy cevchoninates and carboxylic | |
| US3444167A (en) | Process for the production of thiamine derivatives | |
| GB604563A (en) | Improvements in and relating to the purification of penicillin salts | |
| US2862001A (en) | Process for the manufacture of an isoxazolidone compound | |
| US3798212A (en) | Resolution of benzodiazepine derivatives | |
| US3248383A (en) | Benzenesulfonyl-semicarbazides and process for their manufacture | |
| US2983753A (en) | Process of preparing 5beta-hydroxy-8-oxo-1, 4, 4aalpha, 5, 8, 8aalpha-hexahydronaphthalene-1beta-carboxylic acid | |
| US3052687A (en) | Process for the production of | |
| US2666073A (en) | Process for the manufacture of n1-acylated aminoarylsulfonamides | |
| US2838485A (en) | Readily soluble and stable salts of di- |